Senators, vote ‘no’ to RFK Jr. — who’s still a ‘radical left…
Robert F. Kennedy Jr. is still a radical left lunatic who is anti-energy, a “big time” taxer and completely incoherent about our nation’s health.
Related Articles
Patina of precision: risk models for lung cancer screening eligibility
Lung cancer screening is the ugly duckling of our early detection repertoire. Increased adoption could prevent more deaths than equivalent increases in colorectal, breast or…
Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response
Key PointsDNMT3Amt CH is associated with an age- and comorbidity-independent negative impact on COVID-19–related inflammatory outcomes and survival.The neg
A multimodal generative AI copilot for human pathology
Nature – PathChat, a multimodal generative AI copilot for human pathology, has been trained on a large dataset of visual-language instructions to interactively assist users…
Using Generative Artificial Intelligence in Medical… : Academic Medicine
staggering, which comes with promise and peril. This Last Page summarizes some potential LLM uses in medical education.2 However, AI is rapidly advancing, and these…
Journal of Patient-Centered Research and Reviews | Journals | Advocate Health – Midwest
Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal founded in 2014 by Wisconsin-based Aurora Health Care, now a part…
First-in-Human clinical trial of a small molecule EBNA1 inhibitor, VK-2019, in patients with Epstein-Barr positive nasopharyngeal cancer, with pharmacokinetic and pharmacodynamic studies.
Abstract. Purpose: A first-in-human phase one study was conducted in nasopharyngeal carcinoma (NPC) patients to assess the safety and tolerability of VK-2019, a small molecule…
Welcome! You are invited to join a webinar: Post-ASH 2024 MPN highlights webinar. After registering, you will receive a confirmation email about joining the webinar.
Join us to watch leading experts on MPN present summaries on the most significant abstracts from ASH 2024 followed by interactive panel discussions debating current…
CBER-Regulated Products: Current Shortages
A table identifying current shortages of CBER-regulated products. The information contained in the table is generally provided to CBER by the manufacturer of the CBER-regulated…
ASH Clinical News: February 2025 From the Desk Of…
Editor-in-Chief Aaron Gerds, MD, previews what’s to come in ASH Clinical News. Highlights of the February issue include a feature on the recent withdrawal of…
